©2018 Immunicom, Inc. All rights reserved.

6048 CORNERSTONE COURT W

SUITE D, 

SAN DIEGO, CA 92121

  • Black LinkedIn Icon

Healing Reimagined

Reimagine the treatment of cancer

FDA Breakthrough Device Designation

Immunicom awarded  U.S. FDA Breakthrough Device Designation for the treatment of cancer. See details.

ABOUT

A message from Amir Jafri, Founder & CEO

Immunicom seeks to leverage
its technology to address unmet medical needs and improve patient access and affordability of
cancer and other inflammatory and autoimmune disease treatments around the world.

TECHNOLOGY

The industry's 1st  Immunopheresis™

treatment device

Immunicom's revolutionary blood-filtering technology has the potential to effectively treat a wide variety of cancer types including those that have not responded to other treatment strategies including other drug and biological-based immunotherapy options with possibly fewer side effects.

TECHNOLOGY

The industry's 1st  Immunopheresis™

treatment device

Immunicom's revolutionary blood-filtering technology has the potential to effectively treat a wide variety of cancer types including those that have not responded to other treatment strategies including other drug and biological-based immunotherapy options with possibly fewer side effects.

Want to know more?

Tell us about yourself & get in touch.

I am a patient

I am a scientist

I am an investor

Other